Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by QUASCHNING, T.
Right arrow Articles by KRÄMER-GUTH, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by QUASCHNING, T.
Right arrow Articles by KRÄMER-GUTH, A.
J Am Soc Nephrol 10:332-341, 1999
© 1999 American Society of Nephrology


REGULAR ARTICLES

Non-Insulin-Dependent Diabetes Mellitus and Hypertriglyceridemia Impair Lipoprotein Metabolism in Chronic Hemodialysis Patients

THOMAS QUASCHNING*, MICHAEL SCHÖMIG{dagger}, MARKUS KELLER{dagger}, JOACHIM THIERY§, MATTHIAS NAUCK{ddagger}, PETER SCHOLLMEYER{dagger}, CHRISTOPH WANNER* and ANNETTE KRÄMER-GUTH{dagger}

* Department of Medicine, Division of Nephrology, University of Würzburg; Germany.
{dagger} Division of Nephrology University of Freiburg; Germany.
§ Department of Clinical Chemistry, University of Munich, Germany.
{ddagger} Department of Clinical Chemistry, University of Freiburg; Germany.

Correspondence to Dr. Thomas Quaschning, Department of Medicine, Division of Nephrology, University of Würzburg, Josef-Schneider-Strasse 2, D-97080 Würzburg, Germany. Phone: 49 931 201 5330; Fax: 49 931 201 3502; E-mail: thomas.quaschning{at}mail.uni-wuerzburg.de

Abstract. Patients with diabetes mellitus undergoing chronic hemodialysis treatment have the worst outcome on dialysis due to an increased rate of cardiovascular complications. Nearly all patients present with dyslipidemia, a prominent vascular risk factor, probably responsible for the high rate of vascular injury. Since both uremia and diabetes predispose to hypertriglyceridemia, the present study was conducted to investigate the influence of diabetes mellitus and/or hypertriglyceridemia on lipoprotein metabolism in hemodialysis patients. LDL was isolated and characterized from hyper- and normotriglyceridemic diabetic and nondiabetic hemodialysis patients (n = 40; 10 in each group); also, LDL-receptor-dependent uptake and intracellular cholesterol metabolism were studied in HepG2 cells. In addition, scavenger-receptor-mediated uptake was examined in mouse peritoneal macrophages. LDL isolated from nondiabetic normotriglyceridemic hemodialysis patients exhibited impaired cellular uptake via the LDL receptor. Additionally, intracellular sterol synthesis was less inhibited and cholesterol esterification was reduced compared with LDL from healthy control subjects. Reduction of catabolic capacities was more marked in hemodialysis patients who were either diabetic or hypertriglyceridemic and even more pronounced in patients presenting with a combination of both diabetes and hypertriglyceridemia. Hypertriglyceridemic and diabetic patients showed reduced lipase activity and increased LDL oxidation. Furthermore, they accumulated a fraction of small, dense LDL, and LDL was predominantly taken up via the scavenger-receptor pathway in peritoneal macrophages. This study elucidates the distinct influence of diabetes and/or hypertriglyceridemia in hemodialysis patients on cellular LDL metabolism via specific and nonspecific metabolic pathways. Furthermore, it underscores the cumulative impact of these pathologic entities on impairment of lipoprotein metabolism and increase of cardiovascular risk.




This article has been cited by other articles:


Home page
Ann Clin BiochemHome page
Y. Hirowatari, H. Yoshida, Y. Fueki, M. Ito, Y. Ogura, N. Sakurai, and T. Miida
Measurement of cholesterol concentrations of major serum lipoprotein classes in haemodialysis patients by anion-exchange chromatography
Ann Clin Biochem, November 1, 2008; 45(6): 571 - 574.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. Ritz and C. Wanner
Lipid Abnormalities and Cardiovascular Risk in Renal Disease
J. Am. Soc. Nephrol., June 1, 2008; 19(6): 1065 - 1070.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP